Dec 5, 2022 | Jack Aiello
There is no other single conference where so much information is presented about myeloma. Information about so many topics is provided: how to treat MM patients in various stages; results of phase II & III trials which may indicate upcoming FDA approvals;...
Dec 1, 2022 | Linda Huguelet
I’m in my 12th year as a myeloma patient, and this is my 10th year to attend the American Society of Hematology (ASH) Conference. I was reminded of my first ASH recently when I placed a red origami bird, from the Takeda Oncology exhibit booth in 2013, on my Christmas...
